Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and ...

Diagnostics company Guardant Health (NASDAQ:GH) will be reporting earnings tomorrow after market hours. Here’s what you need to know. Guardant Health beat analysts’ revenue expectations by 4.8 ...

With shares of Guardant currently trading around the $51 handle, the purchase of the $47 regular December put option, the sale of two $45 put options, and then the purchase of one corresponding ...

Precision oncology company Guardant Health was hit with an $83.4 million verdict by a jury in Delaware federal court, which found that its cancer-testing kits violate the patent rights of biotech ...

The initial conversion rate of the New Notes will be 16.0716 shares of Guardant Health’s common stock (the “common stock”), per $1,000 principal amount of New Notes, which represents an ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that studies utilizing its portfolio of blood tests and real-world ...